Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB26FATZG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,165
Award facts
- Contract value 100% obligated
- $6,165.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $6,165.36 to DMS Pharmaceutical Group Inc. on October 27, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its location in Conshohocken, Pennsylvania. The contract utilizes firm fixed-price terms with no set-aside designation, indicating the award was made through open competition. The ultimate completion date is November 18, 2025.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, and includes a 30-month base period plus three 30-month option periods. DMS Pharmaceutical Group's established performance across numerous delivery orders for branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals demonstrates its capability to fulfill the diverse medical supply requirements of the federal military healthcare system.
Quick answers
Who was awarded contract SPE2DB26FATZG?
SPE2DB26FATZG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FATZG worth?
The government has obligated $6,165 on SPE2DB26FATZG.
Is contract SPE2DB26FATZG an order under another contract?
Yes. SPE2DB26FATZG is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZG competed?
The extent of competition for SPE2DB26FATZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award